The javascript used on this site for creative design effects is not supported by your browser. Please note that this will not affect access to the content on this web site.
Skip Navigation
U.S. Department of Health and Human Services
  • YouTube
  • HRSA eNews
  • Print this
  • Email this

Understanding U.S. Patient Survival Probability Estimates

Sample Report : Acute Myeloid Leukemia – 1st remission
From 2003 through 2008

  • When the patients in this report received a bone marrow or umbilical cord blood transplant, their Acute Myeloid Leukemia (AML) was in remission after receiving treatment. (Remission means the disease responded well to treatment.)
  • These transplants were performed between January 1, 2003 and December 31, 2008. The data were reported voluntarily by transplant centers in the United States. (More transplants to treat this disease may have been performed, but the data were not reported to the Center for International Blood and Marrow Transplant Research® or the National Marrow Donor Program®.)

U.S. Patient Survival Probability Estimates.  [detailed explanation]